These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37749340)

  • 21. A cabbit in sheep's clothing: exploring the sources of our moral disquiet about cloning.
    Renick TM
    Annu Soc Christ Ethics; 1998; 18():259-74. PubMed ID: 12528707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of the sheep BMPR-IB gene by CRISPR/Cas9 in in vitro-produced embryos.
    Zhang X; Li W; Wu Y; Peng X; Lou B; Wang L; Liu M
    Theriogenology; 2017 Mar; 91():163-172.e2. PubMed ID: 28108032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning special: Dolly: a hard act to follow.
    Check E
    Nature; 2007 Feb; 445(7130):802. PubMed ID: 17314940
    [No Abstract]   [Full Text] [Related]  

  • 24. Animal breeding in the age of biotechnology: the investigative pathway behind the cloning of Dolly the sheep.
    García-Sancho M
    Hist Philos Life Sci; 2015 Sep; 37(3):282-304. PubMed ID: 26205201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Somatic Cell Nuclear Transfer Followed by CRIPSR/Cas9 Microinjection Results in Highly Efficient Genome Editing in Cloned Pigs.
    Sheets TP; Park CH; Park KE; Powell A; Donovan DM; Telugu BP
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27918485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dolly-her life and legacy.
    Wilmut I
    Cloning Stem Cells; 2003; 5(2):99-100. PubMed ID: 12930620
    [No Abstract]   [Full Text] [Related]  

  • 27. CRISPR-edited babies arrived, and regulators are still racing to catch up.
    Opar A
    Nat Med; 2019 Nov; 25(11):1634-1636. PubMed ID: 31649350
    [No Abstract]   [Full Text] [Related]  

  • 28. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dolly, Polly et al.: cloning by somatic cell nucleus transfer].
    Moradpour D; Blum HE
    Dtsch Med Wochenschr; 1999 Mar; 124(9):255-6. PubMed ID: 10102011
    [No Abstract]   [Full Text] [Related]  

  • 31. Focus on CRISPR tools and therapies.
    Nat Biotechnol; 2020 Jul; 38(7):765. PubMed ID: 32641851
    [No Abstract]   [Full Text] [Related]  

  • 32. How genome editing could be used in the treatment of cardiovascular diseases.
    Musunuru K
    Per Med; 2018 Mar; 15(2):67-69. PubMed ID: 29714123
    [No Abstract]   [Full Text] [Related]  

  • 33. Writing the Story of Gene Editing and CRISPR: An Interview with Kevin Davies, PhD.
    Flotte TR
    Hum Gene Ther; 2020 Dec; 31(23-24):1217-1220. PubMed ID: 33337270
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent progress and problems in animal cloning.
    Tsunoda Y; Kato Y
    Differentiation; 2002 Jan; 69(4-5):158-61. PubMed ID: 11841470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Treasure trove' of new CRISPR systems holds promise for genome editing.
    Reardon S
    Nature; 2023 Dec; 624(7990):17-18. PubMed ID: 37996748
    [No Abstract]   [Full Text] [Related]  

  • 36. Plenary Symposia.
    In Vitro Cell Dev Biol Anim; 2018 Jun; 54(Suppl 1):2-5. PubMed ID: 29700742
    [No Abstract]   [Full Text] [Related]  

  • 37. The epigenome editors: How tools such as CRISPR offer new details about epigenetics.
    Willyard C
    Nat Med; 2017 Aug; 23(8):900-903. PubMed ID: 28777784
    [No Abstract]   [Full Text] [Related]  

  • 38. EPO revokes Broad's CRISPR patent.
    Harrison C
    Nat Biotechnol; 2018 Mar; 36(3):209. PubMed ID: 29509734
    [No Abstract]   [Full Text] [Related]  

  • 39. CRISPR target prediction remains blunt tool for clinical applications.
    Hodgson J
    Nat Biotechnol; 2019 Mar; 37(3):204-205. PubMed ID: 30833770
    [No Abstract]   [Full Text] [Related]  

  • 40. The emerging patent landscape of CRISPR-Cas gene editing technology.
    Egelie KJ; Graff GD; Strand SP; Johansen B
    Nat Biotechnol; 2016 Oct; 34(10):1025-1031. PubMed ID: 27727218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.